Declaration of Non-Applicability of Regulation 23(9) of SEBI (LODR) Regulation, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Limited has informed BSE that Regulation 23(9) of SEBI's Listing Obligations does not apply to the company. This regulation deals with disclosure of Related Party Transactions on a half-yearly basis. The exemption applies because the company's paid-up share capital is below Rs. 10 crore and its net worth is below Rs. 25 crore as on March 31, 2025, which makes it eligible under Regulation 15(2). Therefore, the company is not required to submit Related Party Transaction disclosures. The letter is signed by Director Ashok Somani (DIN 03063364) and addressed to BSE's Department of Corporate Services.
This is a routine compliance filing confirming that the company qualifies for exemption from Related Party Transaction disclosure requirements due to its small size. There is no material impact on shareholders or the stock price — it simply means the company falls below the threshold for certain corporate governance disclosures.